flucytosine and posaconazole

flucytosine has been researched along with posaconazole in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (9.09)	18.2507
2000's	18 (54.55)	29.6817
2010's	11 (33.33)	24.3611
2020's	1 (3.03)	2.80

Authors

Authors	Studies
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA	1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C	1
Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	2
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA	1
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, RN; Messer, S; Pfaller, MA	1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA	1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ	1
Barchiesi, F; Bocanegra, R; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Giacometti, A; Giannini, D; Graybill, JR; Najvar, LK; Scalise, G; Schimizzi, AM	1
Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM	1
Steinbach, WJ	1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C	1
Chen, SC; Sorrell, TC	1
Andes, D; Smith, J	1
Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O	1
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A	1
Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D	1
Allada, G; Garrett, L; Marr, K; West, S	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA	1
Bulanda, M; Jagielski, T; Skóra, M	1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W	1
Canteros, CE; Córdoba, S; Davel, G; Hevia, A; Isla, G; Szusz, W; Vivot, W	1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Pea, F	1

Reviews

5 review(s) available for flucytosine and posaconazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Antifungal agents. The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7 Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2007
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Therapeutic drug monitoring, 2008, Volume: 30, Issue:2 Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole	2008
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis. Mycoses, 2020, Volume: 63, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole	2020

Other Studies

28 other study(ies) available for flucytosine and posaconazole

Article	Year
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
In vitro antifungal susceptibilities of five species of sporothrix. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis	2008
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles	2009
In vitro activity of thimerosal against ocular pathogenic fungi. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles	1997
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi. Mycopathologia, 1998, Volume: 141, Issue:2 Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles	1998
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Journal of clinical microbiology, 1999, Volume: 37, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	1999
Interactions of posaconazole and flucytosine against Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5 Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles	2001
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3 Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles	2004
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts	2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole	2006
In vitro susceptibility of Cryptococcus gattii clinical isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:7 Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles	2008
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole. Medical mycology, 2009, Volume: 47, Issue:2 Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2009
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
74-year-old man from the pacific northwest with fever and a lung mass. Chest, 2011, Volume: 140, Issue:3 Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus gattii; Flucytosine; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Radiography; Triazoles	2011
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Mycoses, 2015, Volume: 58, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole	2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole	2015
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Mycoses, 2016, Volume: 59, Issue:6 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses, 2018, Volume: 61, Issue:7 Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Sequence Analysis, DNA; Soil Microbiology; Sporothrix; Sporotrichosis; Triazoles	2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1 Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2018
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019